These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 27414023)

  • 1. The Fatty Kidney: Obesity and Renal Disease.
    Praga M; Morales E
    Nephron; 2017; 136(4):273-276. PubMed ID: 27414023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.
    Xu T; Sheng Z; Yao L
    Front Med; 2017 Sep; 11(3):340-348. PubMed ID: 28791668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-related glomerulopathy: an emerging epidemic.
    Kambham N; Markowitz GS; Valeri AM; Lin J; D'Agati VD
    Kidney Int; 2001 Apr; 59(4):1498-509. PubMed ID: 11260414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fatty Kidney and Beyond: A Silent Epidemic.
    Hti Lar Seng NS; Lohana P; Chandra S; Jim B
    Am J Med; 2023 Oct; 136(10):965-974. PubMed ID: 37451390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which Patients with Obesity Are at Risk for Renal Disease?
    Sandino J; Luzardo L; Morales E; Praga M
    Nephron; 2021; 145(6):595-603. PubMed ID: 33677441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.
    D'Agati VD; Chagnac A; de Vries AP; Levi M; Porrini E; Herman-Edelstein M; Praga M
    Nat Rev Nephrol; 2016 Aug; 12(8):453-71. PubMed ID: 27263398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis.
    Praga M; Hernández E; Morales E; Campos AP; Valero MA; Martínez MA; León M
    Nephrol Dial Transplant; 2001 Sep; 16(9):1790-8. PubMed ID: 11522860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-related glomerulopathy and the nephron complement.
    Tsuboi N; Utsunomiya Y; Hosoya T
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv108-13. PubMed ID: 23868145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Overweight and obesity--risk factors in the development and progression of renal disease].
    Sebeková K; Klassen A; Bahner U; Heidland A
    Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention.
    Yang S; Cao C; Deng T; Zhou Z
    Kidney Blood Press Res; 2020; 45(4):510-522. PubMed ID: 32498064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A big boy with proteinuria. Focal and segmental glomerulosclerosis.
    Quinlan C; Dorman T; Gill D
    Pediatr Nephrol; 2008 Dec; 23(12):2175-8. PubMed ID: 18704510
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary focal segmental glomerulosclerosis in non-obese patients with increased muscle mass.
    Schwimmer JA; Markowitz GS; Valeri AM; Imbriano LJ; Alvis R; D'Agati VD
    Clin Nephrol; 2003 Oct; 60(4):233-41. PubMed ID: 14579937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.
    Darouich S; Goucha R; Jaafoura MH; Zekri S; Ben Maiz H; Kheder A
    Ultrastruct Pathol; 2011 Aug; 35(4):176-82. PubMed ID: 21657818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renovascular hypertension may cause nephrotic range proteinuria and focal glomerulosclerosis in contralateral kidney.
    Ubara Y; Hara S; Katori H; Yamada A; Morii H
    Clin Nephrol; 1997 Oct; 48(4):220-3. PubMed ID: 9352155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery.
    Fowler SM; Kon V; Ma L; Richards WO; Fogo AB; Hunley TE
    Pediatr Nephrol; 2009 Apr; 24(4):851-5. PubMed ID: 18941798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there an obesity-metabolic syndrome related glomerulopathy?
    Ritz E; Koleganova N; Piecha G
    Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):44-9. PubMed ID: 21088574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and chronic kidney disease.
    Eknoyan G
    Nefrologia; 2011; 31(4):397-403. PubMed ID: 21623393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal disease in patients with massive obesity.
    Kasiske BL; Crosson JT
    Arch Intern Med; 1986 Jun; 146(6):1105-9. PubMed ID: 3718096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural renal changes in obesity and diabetes.
    Amann K; Benz K
    Semin Nephrol; 2013 Jan; 33(1):23-33. PubMed ID: 23374891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.